Vertex Pharmaceuticals

About:

Vertex Pharmaceuticals is focused on the discovery and development of small molecule drugs for the treatment of serious diseases.

Website: http://www.vrtx.com

Twitter/X: VertexPharma

Top Investors: Morgan Stanley, Goldman Sachs, New Enterprise Associates, Norwest Venture Partners, Greylock

Description:

Vertex Pharmaceuticals is a biotechnology company committed to the discovery and development of breakthrough small molecule drugs for serious diseases. The Company's strategy is to commercialize its products both independently and in collaboration with major pharmaceutical companies. Vertex's product pipeline is focused on viral diseases, cystic fibrosis, inflammation, autoimmune diseases, cancer, and pain.

Total Funding Amount:

$657M

Estimated Revenue Range:

$500M to $1B

Headquarters Location:

Boston, Massachusetts, United States

Founded Date:

1989-01-01

Contact Email:

mediainfo(AT)vrtx.com

Founders:

Joshua Boger, Larry Bock

Number of Employees:

1001-5000

Last Funding Date:

2024-07-10

IPO Status:

Public

© 2025 bioDAO.ai